Danaher Corp
BMV:DHR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Danaher Corp
BMV:DHR
|
US |
|
T
|
Teva Pharmaceutical Industries Ltd
BMV:TEVAN
|
IL |
|
S
|
Sanyu Co Ltd
TSE:5697
|
JP |
|
P
|
ProKidney Corp
NASDAQ:PROK
|
US |
|
IZEA Worldwide Inc
NASDAQ:IZEA
|
US |
|
Jfrog Ltd
NASDAQ:FROG
|
US |
|
Idorsia Ltd
SIX:IDIA
|
CH |
Wall St Price Targets
DHR Price Targets Summary
Danaher Corp
According to Wall Street analysts, the average 1-year price target for
DHR is 3 816.42 MXN with a low forecast of 3 267 MXN and a high forecast of 5 399.38 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DHR's stock price target?
Price Target
3 816.42
MXN
According to Wall Street analysts, the average 1-year price target for
DHR is 3 816.42 MXN with a low forecast of 3 267 MXN and a high forecast of 5 399.38 MXN.
What is the Revenue forecast for Danaher Corp?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 5 years is 7%.
What is the Gross Profit forecast for Danaher Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 5 years is 8%.
What is the Operating Income forecast for Danaher Corp?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 12%.
What is the Pre-Tax Income forecast for Danaher Corp?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Danaher Corp?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 5 years is 20%.